Area of research
Physiology · Surgery
Research interest
Research focused on Mepolizumab and Asthma, with related work in COPD, Placebo, Hypereosinophilic syndrome. Notable publications include 'Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease', 'Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind,...', and 'Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma'.
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial
Multinational cohort study of mortality in patients with asthma and severe asthma
Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study
Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine
Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype
Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA
Efficacy Of 100 Mg SC Mepolizumab For Severe Eosinophilic Asthma (SEA) Across Body Weight: Meta-Analysis
Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis
Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
The value of blood cytokines and chemokines in assessing COPD
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Physiology · Surgery →